Provided by Tiger Trade Technology Pte. Ltd.

Geron

1.34
-0.0600-4.29%
Post-market: 1.350.0101+0.75%17:41 EST
Volume:5.50M
Turnover:7.45M
Market Cap:855.40M
PE:-11.15
High:1.43
Open:1.40
Low:1.33
Close:1.40
52wk High:3.99
52wk Low:1.04
Shares:638.36M
Float Shares:534.08M
Volume Ratio:0.50
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1201
EPS(LYR):-0.2702
ROE:-29.57%
ROA:-7.79%
PB:3.44
PE(LYR):-4.96

Loading ...

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
1 hour ago

Investor Says He 'Doubled' His Savings After Using ChatGPT in Stock Research – Shares Top 5 Stock Picks

Benzinga_recent_news
·
4 hours ago

Geron Corp - Begins Strategic Restructuring Plan - SEC Filing

THOMSON REUTERS
·
Dec 17

Geron Corporation Announces Workforce Reduction and $18 Million Restructuring Charge

Reuters
·
Dec 17

Geron Shares up 2.3% Premarket; Co Announces Strategic Restructuring Plan to Reduce Workforce by One-Third

THOMSON REUTERS
·
Dec 11

BRIEF-Geron Corporation Announces Strategic Restructuring Plan To Position The Company For Long-Term Value Creation

Reuters
·
Dec 11

Geron Corporation Cuts Workforce by One-Third in Strategic Restructuring

Reuters
·
Dec 11

Geron Corp - 2026 Operating Expenses Expected to Be Less Than 2025

THOMSON REUTERS
·
Dec 11

Geron Corp - Restructuring Plan to Reduce Workforce by One-Third

THOMSON REUTERS
·
Dec 11

Geron Corp - to Incur Cash-Based Restructuring Charges

THOMSON REUTERS
·
Dec 11

Geron Corp: Reduction in Geron's Current Workforce of About 260 Employees

THOMSON REUTERS
·
Dec 11

Geron Corp: Restructuring Plan Is Expected to Be Substantially Complete in Q1 of 2026

THOMSON REUTERS
·
Dec 11

Press Release: Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation

Dow Jones
·
Dec 11

Geron Corporation Reports on IL-8 and TNF-Alpha Correlation with Survival in Myelofibrosis Patients Treated with Imetelstat

Reuters
·
Dec 08

Geron Corporation Releases Phase 1b Trial Results on Imetelstat Plus Ruxolitinib for Myelofibrosis

Reuters
·
Dec 08

Geron Corporation publishes analysis on imetelstat treatment-emergent cytopenias and clinical response in lower-risk myelodysplastic syndromes

Reuters
·
Dec 08

Geron Unveils New Data Showing RYTELO Improves Outcomes in Lower-Risk MDS

Reuters
·
Dec 08

Geron Q3 EPS USD -0.03

Reuters
·
Nov 20

Wedbush Cuts Price Target on Geron to $5 From $6, Keeps Outperform Rating

MT Newswires Live
·
Nov 06

Stock Track | Geron Soars 9.17% Pre-Market Following Q3 Earnings and Positive Analyst Outlook

Stock Track
·
Nov 06